• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A confirmed asymptomatic carrier of 2019 novel coronavirus.

作者信息

Luo Si-Hui, Liu Wei, Liu Zhen-Jun, Zheng Xue-Ying, Hong Chang-Xing, Liu Zhi-Rong, Liu Jian, Weng Jian-Ping

机构信息

The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230001, China.

Joint Laboratory of Public Health, University of Science and Technology of China and Health Commission of Anhui Province, Hefei, Anhui 230026, China.

出版信息

Chin Med J (Engl). 2020 May 5;133(9):1123-1125. doi: 10.1097/CM9.0000000000000798.

DOI:10.1097/CM9.0000000000000798
PMID:32149768
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7213620/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f90/7213620/908b264d586c/cm9-133-1123-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f90/7213620/908b264d586c/cm9-133-1123-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f90/7213620/908b264d586c/cm9-133-1123-g001.jpg

相似文献

1
A confirmed asymptomatic carrier of 2019 novel coronavirus.一名确诊的2019新型冠状病毒无症状携带者。
Chin Med J (Engl). 2020 May 5;133(9):1123-1125. doi: 10.1097/CM9.0000000000000798.
2
Presumed Asymptomatic Carrier Transmission of COVID-19.新冠病毒无症状感染者的传播。
JAMA. 2020 Apr 14;323(14):1406-1407. doi: 10.1001/jama.2020.2565.
3
High proportion of asymptomatic and presymptomatic COVID-19 infections in air passengers to Brunei.高比例无症状和出现症状前的 COVID-19 感染病例在飞往文莱的航空旅客中。
J Travel Med. 2020 Aug 20;27(5). doi: 10.1093/jtm/taaa066.
4
Presumptive asymptomatic COVID-19 carriers' estimation and expected person-to-person spreading among repatriated passengers returning from China.从中国返回的归国乘客中推定无症状新冠病毒携带者的估计及预期人际传播情况。
Travel Med Infect Dis. 2020 Sep-Oct;37:101688. doi: 10.1016/j.tmaid.2020.101688. Epub 2020 Apr 21.
5
[Advances on presymptomatic or asymptomatic carrier transmission of COVID-19].[新型冠状病毒肺炎症状前或无症状携带者传播的研究进展]
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Apr 10;41(4):485-488. doi: 10.3760/cma.j.cn112338-20200228-00207.
6
Letter to the Editor: "Asymptomatic Carrier Transmission of Coronavirus Disease 2019 (COVID-19) and Multipoint Aerosol Sampling to Assess Risks in the Operating Room During a Pandemic".致编辑的信：“2019冠状病毒病（COVID-19）的无症状携带者传播以及多点气溶胶采样以评估大流行期间手术室的风险”
World Neurosurg. 2020 Oct;142:577. doi: 10.1016/j.wneu.2020.07.144. Epub 2020 Jul 27.
7
Mild and asymptomatic cases of COVID-19 are potential threat for faecal-oral transmission.新冠病毒病轻症和无症状病例存在粪口传播的潜在风险。
Braz J Infect Dis. 2020 Jul-Aug;24(4):368. doi: 10.1016/j.bjid.2020.06.003. Epub 2020 Jun 28.
8
The engines of SARS-CoV-2 spread.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）传播的驱动因素。
Science. 2020 Oct 23;370(6515):406-407. doi: 10.1126/science.abd8755.
9
A hundred days into the coronavirus disease (COVID-19) pandemic.新型冠状病毒肺炎（COVID-19）疫情爆发一百天之际。
Euro Surveill. 2020 Apr;25(14). doi: 10.2807/1560-7917.ES.2020.25.14.2000550.
10
Estimating the risk of an anaesthetist acquiring COVID-19 by anaesthetising an asymptomatic patient.评估麻醉医生通过为无症状患者实施麻醉而感染新型冠状病毒肺炎的风险。
Anaesth Intensive Care. 2020 Jul;48(4):325-327. doi: 10.1177/0310057X20937316. Epub 2020 Jul 6.

引用本文的文献

1
COVID-19: from immune response to clinical intervention.新型冠状病毒肺炎：从免疫反应到临床干预
Precis Clin Med. 2024 Jul 18;7(3):pbae015. doi: 10.1093/pcmedi/pbae015. eCollection 2024 Sep.
2
ANMCO POSITION PAPER: Network Organization for the Treatment of Acute Coronary Syndrome Patients during the Emergency COVID-19 Pandemic.意大利心脏病学国家协会立场文件：2019年冠状病毒病疫情紧急期间急性冠状动脉综合征患者的网络治疗组织
Eur Heart J Suppl. 2020 Aug;22(Suppl G):G223-G227. doi: 10.1093/eurheartj/suaa111. Epub 2020 Aug 27.
3
Lockdown Without Loss? A Natural Experiment of Net Payoffs from COVID-19 Lockdowns.
封锁却无损失？新冠疫情封锁净收益的自然实验。
J Public Policy Mark. 2023 Apr;42(2):133-151. doi: 10.1177/07439156221143954. Epub 2023 Jan 10.
4
Innate and adaptive immunity to SARS-CoV-2 and predisposing factors.固有免疫和适应性免疫对 SARS-CoV-2 及相关影响因素。
Front Immunol. 2023 May 9;14:1159326. doi: 10.3389/fimmu.2023.1159326. eCollection 2023.
5
Immunologic features of asymptomatic postvaccination infections with the Delta variant of SARS-CoV-2 in adults.接种疫苗后无症状感染 SARS-CoV-2 的 Delta 变异株的免疫特征。
Immun Inflamm Dis. 2022 Jul;10(7):e670. doi: 10.1002/iid3.670.
6
Epidemiological characteristics and outcomes of COVID-19 in asymptomatic versus symptomatic patients.无症状与有症状 COVID-19 患者的流行病学特征和结局。
J Prev Med Hyg. 2022 Jan 31;62(4):E854-E858. doi: 10.15167/2421-4248/jpmh2021.62.4.2254. eCollection 2021 Dec.
7
Bulbus Fritillariae Cirrhosae as a Respiratory Medicine: Is There a Potential Drug in the Treatment of COVID-19?川贝母作为一种呼吸医学药物：它在治疗新冠肺炎方面有成为潜在药物的可能吗？
Front Pharmacol. 2022 Jan 20;12:784335. doi: 10.3389/fphar.2021.784335. eCollection 2021.
8
Asymptomatic patients and asymptomatic phases of Coronavirus Disease 2019 (COVID-19): a population-based surveillance study.2019冠状病毒病（COVID-19）的无症状患者和无症状阶段：一项基于人群的监测研究。
Natl Sci Rev. 2020 Jun 23;7(10):1527-1539. doi: 10.1093/nsr/nwaa141. eCollection 2020 Oct.
9
EVALUATION OF THE RELATIONSHIP OF MPV, RDW AND PVI PARAMETERS WITH DISEASE SEVERITY IN COVID-19 PATIENTS.评价MPV、RDW 和 PVI 参数与 COVID-19 患者疾病严重程度的关系。
Acta Clin Croat. 2021 Mar;60(1):103-114. doi: 10.20471/acc.2021.60.01.15.
10
How is the iceberg of COVID-19? Results from a rapid literature review.新冠病毒病的“冰山”情况如何？快速文献综述结果
Med J Islam Repub Iran. 2021 Jun 16;35:77. doi: 10.47176/mjiri.35.77. eCollection 2021.